A novel marker of lung-cancer risk in people with HIV - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Lancet HIV Année : 2017

A novel marker of lung-cancer risk in people with HIV

Résumé

Since the advent of combination antiretroviral therapy (ART), a shift in mortality and morbidity has been noted in people living with HIV from AIDS to non-AIDS diseases, among which non-AIDS-defining cancers are prominent.1 In people living with HIV, lung cancer is more common than any other non-AIDS-defining malignant disease, and mortality associated with lung cancer exceeds that associated with any other AIDS-defining or non-AIDS-defining cancers.
Fichier non déposé

Dates et versions

hal-01797816 , version 1 (22-05-2018)

Identifiants

Citer

Alain Makinson, Jacques Reynes. A novel marker of lung-cancer risk in people with HIV. Lancet HIV, 2017, 4 (2), pp.e53 - e55. ⟨10.1016/S2352-3018(16)30218-1⟩. ⟨hal-01797816⟩
39 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More